GRO Network™ Brings Environmental Transparency to Grain Market
1.9.2020 15:30:00 EEST | Business Wire | Press release
Farmer’s Business Network, Inc. (FBNSM), the leading direct-to-farm ag tech platform and farmer network, today launched GRO Network™, which provides new technology and services that facilitate the scoring, sourcing, and pricing of Low-Carbon Grain from farm to fork, making environmental transparency in the grain industry a reality now.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901005290/en/
GRO Network enables comprehensive environmental transparency, and supports a market for premium, environmentally-scored grain. GRO Network also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the world’s other major grain buyers.
POET, the world’s largest producer of biofuels has joined GRO Network as a key customer in the market for verifiable Low-Carbon Grain.
“Family farms have already invested the time, innovation and sweat-equity to develop the regenerative practices required to grow Low-Carbon Grain,” said Amol Deshpande, CEO and Co-Founder of FBN. “With GRO Network, the efforts of farmers as well as food and feed companies, biofuel makers, and ordinary consumers to reduce carbon emissions just got a huge boost.”
Transparency in the agriculture supply chain starts with data direct from the field.
Farmers share information on their cultivation practices - including fertilizer applications, tillage, and cover cropping - with GRO Network, which is processed with artificial intelligence that leverage FBN’s 240 million acre-events of real world farm data, validates and distills the practices into a single farm-level score. This single score - which is the only information shared between GRO Network and prospective buyers - informs the buyer to then source premium grain as well as build programs to meet unique sustainability goals, while protecting farmers’ data privacy.
Importantly, verifiable Low-Carbon Grain will allow agricultural processors and food companies to meet their own significant emission goals. Policymakers will be able to evaluate a precise, farm-level carbon-intensity score to more accurately measure the GHG reduction of biofuels for low carbon fuel policies. GRO Network will help these companies embed the required carbon traceability into their supply chains, all within the current government policy framework.
“At POET we know that agriculture is the key to combating climate change, and we want to support farmers who share our mission to be good stewards of the earth by using environmentally friendly practices,” said POET Founder and CEO Jeff Broin. “We are excited about the potential of the GRO Network to promote sustainable agriculture and utilize the resulting Low-Carbon Corn to produce even greener bioethanol and bioproducts.”
GRO Network is focusing initially on carbon abatement, which, based on GRO Network pilots, can reduce grain emissions by up to 50%, while increasing farm revenues at the same time. It relies on proven, existing science and robust FBN analytics to measure the benefits of conservation activities on the farm, providing immediate, low-risk solutions to reduce the environmental impact of the agriculture supply chain.
“Regenerative agriculture techniques have not only saved us money, they’ve made us money,” said Todd Hanten, who farms 3,000 acres of corn, soybeans and spring wheat in South Dakota. “We’ve always tried these practices side by side and can compare conventional tillage to no-till and strip till and we’ve realized the benefits through our data analytics. We’re happy to find out that the practices we’ve adopted are saving us money and making us a better return.”
FBN began development of GRO Network close to two years ago in order to allow fuel, food and feed companies to work alongside farmers to accelerate the adoption of regenerative agricultural practices that deliver the biggest impact. GRO Network incentivizes sustainable conservation and soil health practices by producers, ensuring a consistent supply of high quality, Low-Carbon Grain for buyers.
“Ultimately, GRO Network aligns farmers, processors, brands, consumers and policy-makers in the fight against climate change,” Deshpande said. “We are excited to see family farm incomes improve as a direct result.”
Learn more at www.fbngro.com
About FBN:
Farmer’s Business Network, Inc. is an independent ag tech platform and farmer-to-farmer network with a mission to power the prosperity of family farmers around the world, while working towards a sustainable future. Its Farmers First® promise has attracted over 14,000 members to the network with a common goal of maximizing their farm’s profit potential. FBN has set out to redefine value and convenience for farmers by helping reduce the cost of production and maximize the value of their crops.
The FBN network has grown to cover more than 40 million acres of member farms in the U.S., Canada and Australia. Blending the best of Midwestern agricultural roots and Silicon Valley technology, the company has over 600 personnel and offices in San Carlos, Calif., Chicago, Sioux Falls, S.D., a Canadian headquarters in High River, Alta., and an Australian headquarters in Perth.
To learn more, visit: www.fbn.com.
Copyright ©2020 Farmer's Business Network, Inc. All rights reserved. The sprout logo, “Farmers Business Network”, “FBN”, “Farmers First” and the Farmers First flag logo are registered service marks of Farmer’s Business Network, Inc. All other marks are the property of their respective owners.
Copyright ©2020 GRO Network. All rights reserved. “GRO Network” and the GRO Network logo are registered trademarks of GRO Network.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200901005290/en/
Contact information
Media:
Keith Chapman
Chap Public Relations
Keith@chappublicrelations.com
847-970-2171
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
